Programs: Public Health
- MD: University of California, Davis, School of Medicine
- MBA: Haub School of Business, St. Joseph’s University, Philadelphia
Development process of new drugs, biologics, vaccines, and medical devices • Pharmacovigilance, including signal management and benefit-risk management • Regulatory science
Beninger P, Boumil M, Berman H, Getz K, Klapholtz H, Jotwani R, Salem D.Bridging the Academia/ Industry Chasm: Proposed Solutions. Journal Clinical Pharmacology 56(12):1457-1460; 2016.
Beninger P, Boumil M. Jotwani R. Medical Schools' Competition for Clinical Training Sites [Letter]. Academic Medicine. 91:1588; 2016.
Beninger P. Pharmacovigilance in the New Millennium (Editorial). Clinical Therapeutics 38:2512-2513; 2016.
Beninger P, Ibara M. Pharmacovigilance and Biomedical Informatics: A Model of Future Development. Clinical Therapeutics 38:2514-2525; 2016.
Beninger P. Pharmacovigilance: Work in Progress. Pharmaceutical Medicine 30 (1): 1-5; 2017.